SCHEMBL319638

SCHEMBL319638

O=C(NS(=O)(=O)C(F)(F)F)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.48
CA1 P00915 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CA12 O43570 2/20 0.34
CA9 Q16790 2/20 0.34
MAPK1 P28482 1/20 0.34
CA3 P07451 2/20 0.32
CA5A P35218 2/20 0.32
CA5B Q9Y2D0 2/20 0.32
CA7 P43166 2/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA14 Q9ULX7 1/20 0.32
CA13 Q8N1Q1 1/20 0.30
EPHX1 P07099 2/20 0.30
MMP1 P03956 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2003827 0.97 CA2 (0.46) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL1617168 0.97 CA2 (0.46) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL1618312 0.97 CA2 (0.46) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL30197064 0.97 CA2 (0.46) CA2CA1SMN1; SMN2ALDH1A1POLB
Phosphine SCHEMBL2053857 0.97 CA2 (0.46) CA2CA1SMN1; SMN2ALDH1A1POLB
Lithium SCHEMBL30020591 0.97 CA2 (0.46) CA2CA1SMN1; SMN2ALDH1A1POLB
Ammonia Solution, Strong SCHEMBL2053881 0.97 CA2 (0.46) CA2CA1SMN1; SMN2ALDH1A1POLB
Tetramethylammonium Ion SCHEMBL14953647 0.91 CA2 (0.41) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL1618468 0.85 CA2 (0.40) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL6858552 0.84 CA2 (0.35) CA2CA1SMN1; SMN2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 492 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250112280-A1 LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND Westlake University (CN) 2025-04-03 US claimed
CN-119495793-A Non-negative electrode lithium metal battery and preparation method and application thereof 西湖大学 2025-02-21 CN claimed
WO-2025036379-A1 ANODE-FREE LITHIUM METAL BATTERY, MANUFACTURING METHOD THEREFOR AND USE THEREOF 西湖大学 2025-02-20 WO claimed
CN-119447413-A Non-negative electrode lithium metal battery and preparation method and application thereof 西湖大学 2025-02-14 CN claimed
WO-2025026128-A1 NEGATIVE ELECTRODE-FREE LITHIUM METAL BATTERY, AND PREPARATION METHOD THEREFOR AND USE THEREOF 西湖大学 2025-02-06 WO claimed
EP-4471923-A1 LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND Westlake University (CN) 2024-12-04 EP claimed
US-20240291020-A1 COMPOSITE MATERIAL COMPRISING A FLUORINATED AMIDE AND USES THEREOF IN ELECTROCHEMICAL CELLS HYDRO-QUéBEC (CA) 2024-08-29 US claimed
EP-4356468-A1 COMPOSITE MATERIAL COMPRISING A FLUORINATED AMIDE AND USES THEREOF IN ELECTROCHEMICAL CELLS Hydro-Québec (CA) 2024-04-24 EP claimed
CN-117625109-A Adhesive composition comprising polyurethane and cationic dopant 伊英克公司 2024-03-01 CN claimed
CN-117501498-A Composite materials comprising fluorinated amides and their use in electrochemical cells 魁北克电力公司 2024-02-02 CN claimed
EP-1556390-A4 FUNCTIONALIZED IONIC LIQUIDS, AND METHODS OF USE THEREOF UNIV SOUTH ALABAMA (US) 2007-12-26 EP claimed
US-7208605-B2 Functionalized ionic liquids, and methods of use thereof UNIVERSITY OF SOUTH ALABAMA (US) 2007-04-24 US claimed
US-20060287521-A1 Boronium-ion-based ionic liquids and methods of use thereof UNIVERSITY OF SOUTH ALABAMA (US) 2006-12-21 US claimed
WO-2006125175-A2 BORONIUM-ION-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF UNIVERSITY OF SOUTH ALABAMA (US) 2006-11-23 WO claimed
US-20060057465-A1 Composite polymer electrolyte composition TREKION CO., LTD. (JP) 2006-03-16 US claimed
EP-1612809-A1 COMPOSITE POLYMER ELECTROLYTE COMPOSITION Trekion Co. Ltd. (JP) 2006-01-04 EP claimed
EP-1556390-A2 FUNCTIONALIZED IONIC LIQUIDS, AND METHODS OF USE THEREOF University Of South Alabama (US) 2005-07-27 EP claimed
JP-2005521750-A 2005-07-21 JP claimed
US-20040035293-A1 Functionalized ionic liquids, and methods of use thereof UNIVERSITY OF SOUTH ALABAMA 2004-02-26 US claimed
WO-2003086605-A2 FUNCTIONALIZED IONIC LIQUIDS, AND METHODS OF USE THEREOF UNIVERSITY OF SOUTH ALABAMA (US) 2003-10-23 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250112280-A1 LITHIUM BATTERY ELECTROLYTE HAVING LITHIUM BORATE SALT AND TRIFLUOROACETAMIDE COMPOUND HCN2, SLC9A5, SLC9B2 CA2 127/4885CA1 108/4885SMN1; SMN2 454/4885
US-20040035293-A1 Functionalized ionic liquids, and methods of use thereof TST, SCLY, MPST CA2 150/4885CA1 72/4885SMN1; SMN2 1737/4885
US-20060287521-A1 Boronium-ion-based ionic liquids and methods of use thereof IPO4, SLC9B2, INF2 CA2 274/4885CA1 1017/4885SMN1; SMN2 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.